STOCK TITAN

In Another Win for Masimo, Knobbe Martens Secures Dismissal of Infringement Lawsuit

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

On June 24, 2024, Masimo (NASDAQ: MASI) achieved a significant legal victory with the dismissal of a patent infringement lawsuit filed by Wrist SP Biotech. The lawsuit, initially filed in August 2023, accused Masimo's pulse oximetry sensors of infringing U.S. Patent No. 11,331,015. The case was transferred from the Western District of Texas to the Central District of California, where detailed evidence from Masimo led to the dismissal with no payment. Masimo, represented by the legal team at Knobbe Martens, has seen a series of legal successes, including a permanent injunction against Sotera Wireless and Foxconn, and an import ban on Apple watches that infringed Masimo's technology. CEO Joe Kiani emphasized the company's respect for valid intellectual property and praised the legal team's efforts.

Positive
  • Successful dismissal of patent infringement lawsuit with no payment from Masimo.
  • Transfer of case to a favorable jurisdiction (Central District of California).
  • Recent legal victories, including permanent injunctions and import bans, reinforce Masimo's IP protection.
  • CEO Joe Kiani's positive statement on the legal team's effectiveness.
Negative
  • None.

Insights

Masimo's legal victory over Wrist SP Biotech is a significant development for shareholders. Dismissals with prejudice mean the plaintiff cannot refile the case on the same grounds, effectively ending this particular legal threat. Given that Wrist SP had targeted Masimo's pulse oximetry sensors, which see widespread use, the lawsuit dismissal removes a potential financial liability and operational disruption.

From a legal perspective, the ability of Masimo's defense team to secure this outcome also speaks volumes about the company's preparedness and capability in handling patent infringement claims. While dismissing a non-practicing entity lawsuit might not win any awards, it prevents future financial bleed and preserves the intellectual property integrity of the business. This dovetails neatly with prior wins, such as the import ban on certain Apple Watch models, building a robust legal precedent.

Rating: Positive.

From a financial perspective, the dismissal of the patent infringement lawsuit is a positive development for Masimo Corporation. Legal battles can be costly, not just in terms of legal fees but also in potential settlements. The fact that Masimo had no financial outlay related to this dismissal avoids unexpected expenses that could have dented the company’s earnings. Moreover, this legal victory contributes to investor confidence, supporting stock stability and possibly aiding in share price appreciation.

It’s also worth noting that repeated legal successes, like the recent import ban on Apple watches, may enhance Masimo’s negotiating position in future business dealings. This bolstered legal standing could potentially deter future frivolous lawsuits, saving the company money and operational distractions in the long run.

Rating: Positive.

IRVINE, Calif., June 24, 2024 /PRNewswire/ -- Knobbe Martens secured another victory for Masimo Corporation (NASDAQ: MASI) with the successful dismissal with prejudice of a patent infringement lawsuit filed by Wrist SP Biotech, a non-practicing entity (NPE). This success is the latest in a string of successful results Knobbe Martens has achieved for Masimo. 

In August 2023 Wrist SP filed a complaint in the Western District of Texas, asserting U.S. Patent No. 11,331,015 against Masimo pulse oximetry sensors. In the complaint, Wrist SP accused the majority of Masimo's disposable sensor models, which are used by over 200 million patients annually, of infringement. 

On behalf of Masimo, the Knobbe Martens team first obtained a transfer of the case to the Central District of California. Then, the team worked with Masimo to assemble evidence to support its defense. After a detailed reveal of Masimo's defense in discovery, Wrist SP dismissed the case with no payment from Masimo.

Click here to view the dismissal.

The Knobbe Martens team that represented Masimo in this case was Irfan Lateef and Raymond Lu

This was the most recent success Knobbe Martens has secured on behalf of Masimo. Last month, a team from the firm represented Masimo in litigation resulting in a permanent injunction against Sotera Wireless and Foxconn regarding a patent that pertains to products that monitor vital signs. Earlier this year, the firm scored a momentous success when it secured an import ban on Apple watches that were found to infringe Masimo's patented pulse oximetry technology. 

Commenting on these accomplishments, Masimo CEO Joe Kiani stated, "Masimo is a company that respects valid intellectual property. We are greatly appreciative of the talented and dedicated lawyers at Knobbe Martens who carefully defended these claims on the merits, and delivered an outstanding result."

About Knobbe Martens 

Knobbe Martens is a highly respected intellectual property law firm, offering legal services in all aspects of intellectual property and technology law. The firm's litigation group handles cases throughout the U.S. and coordinates strategy for disputes worldwide. Founded in California in 1962, the firm has about 300 lawyers and scientists based in offices located in Orange County, Los Angeles, New York, San Diego, San Francisco, Seattle and Washington D.C. Knobbe Martens serves a diverse international client base, from multinational corporations to emerging businesses of all stages. More information about the firm can be found at www.knobbe.com

Cision View original content:https://www.prnewswire.com/news-releases/in-another-win-for-masimo-knobbe-martens-secures-dismissal-of-infringement-lawsuit-302178467.html

SOURCE Knobbe Martens

FAQ

What was the outcome of the patent infringement lawsuit against Masimo (MASI) filed by Wrist SP Biotech?

The lawsuit was dismissed with prejudice, with no payment required from Masimo.

When was the patent infringement lawsuit against Masimo filed?

The lawsuit was filed in August 2023.

Which patent was claimed to be infringed by Masimo's pulse oximetry sensors?

The lawsuit claimed infringement of U.S. Patent No. 11,331,015.

How many patients use Masimo's disposable sensor models annually?

Masimo's disposable sensor models are used by over 200 million patients annually.

What other significant legal victories has Masimo achieved recently?

Masimo has achieved a permanent injunction against Sotera Wireless and Foxconn, and an import ban on Apple watches that infringed its technology.

Masimo Corporation

NASDAQ:MASI

MASI Rankings

MASI Latest News

MASI Stock Data

9.12B
49.16M
8.19%
94.77%
6.24%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
IRVINE